Cancer patients across England will soon be offered a new type of gene testing on the NHS that should help doctors tailor their treatment better.
Scientists know that hundreds of different genes are linked to cancer, and they are learning how to test to find out which particular genes are involved, so they can target those particular mutations with the most appropriate treatments. Science and Medical Editor Lawrence McGinty reports.
A microchip test developed by scientists at University College Hospital (UCL) in London analyses 35 different genetic mutations linked to cancer, which then enables doctors to identify and target those particular genes.
Professor Charles Swanton from UCL said the test will enable NHS patients to receive better tailored cancer care.
The future is being able to do many gene tests on a small amount of tissue, and what we are seeing is the beginning of that type of technology impacting on the future on NHS care.